Compare LND & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LND | LAB |
|---|---|---|
| Founded | 2005 | 1999 |
| Country | Brazil | United States |
| Employees | N/A | N/A |
| Industry | Farming/Seeds/Milling | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Staples | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 353.6M | 394.3M |
| IPO Year | N/A | 2008 |
| Metric | LND | LAB |
|---|---|---|
| Price | $3.81 | $1.03 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $1.35 |
| AVG Volume (30 Days) | 77.2K | ★ 2.0M |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | ★ 3.18% | N/A |
| EPS Growth | N/A | ★ 61.54 |
| EPS | N/A | ★ 0.33 |
| Revenue | N/A | ★ $101,937,000.00 |
| Revenue This Year | $1.65 | N/A |
| Revenue Next Year | $6.42 | $2.63 |
| P/E Ratio | ★ N/A | $3.12 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.47 | $0.87 |
| 52 Week High | $4.45 | $1.72 |
| Indicator | LND | LAB |
|---|---|---|
| Relative Strength Index (RSI) | 45.56 | 58.21 |
| Support Level | $3.77 | $0.92 |
| Resistance Level | $4.29 | $1.38 |
| Average True Range (ATR) | 0.09 | 0.05 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 46.55 | 73.88 |
Brasilagro - Cia Bras de Prop Agricolas is a Brazil-based company, engaged in the acquisition, development, operation, and sale of rural properties suitable for agricultural activities. The business activity of the firm is operated through Real estate, Grains, Sugarcane, Cattle rising, Cotton, and Other segments. The Grains segment is involved in the production and sale of soybean and corn. The Sugarcane segment includes the sale of raw product. The Real Estate segment presents the P&L from operations carried out in the company's subsidiaries. The Cattle Raising segment consists of producing and selling beef calves after weaning, which characterizes the activity as breeding and the Other segment engages in other corporate activities. The majority of revenue is earned from Grain Segment.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. The company operates in one segment. Its technology includes: Genomics; Single-cell proteomics; Spatial proteomics. Its platforms include: Biomark X9 System, CyTOF XT system, and Hyperion XTi Imaging System. The company offers a diverse range of instrumentation, consumables, and services that generate high-quality data across early discovery, translational and clinical research. Geographically, it operates in Americas; EMEA and Asia-Pacific.